A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
NCT01465763
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
614
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
tofacitinib
DRUG:
Placebo
Sponsor
Pfizer